Publication of Final Terms
The Bank of Nova Scotia Canada has agreed to issue £250,000,000 1.250 per cent. Notes due June 8 2022 (the "Notes") pursuant to its US$20,000,000 Euro Medium Term Note Programme (the "Programme").
The following document constitutes the final terms dated June 6 2017 (the "Final Terms") in relation to the admission to trading of the Notes for purpose of Article 5.4 of Directive 2003/71/EC and must be read in conjunction with the Prospectus dated 28 June 2016 and the supplemental prospectuses dated 31 August 2016, November 30, 2016, March 1, 2017, May 22, 2017 and May 31, 2017 (together, the "Prospectus") for the Programme. Full information on The Bank of Nova Scotia and the offer of the Notes is only available on the basis of the combination of the Final Terms and the Prospectus.
To view the Final Terms, please paste the following URLs into the address bar of your browser.
For further information, please contact
The Bank of Nova Scotia
40 King Street West
Canada M5H 1H1
Attn: Managing Director, Secured & Capital Funding
Tel: 001 416 933 7974
Fax: 001 416 945 4001
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus and the Final Terms, may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in the Final Terms you must ascertain from the Prospectus, as supplemented by the Final Terms, whether or not you are part of the intended addressees of the information contained therein.
The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") and are subject to US tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered in or into the United States or to or for the account or benefit of US persons (as defined in Regulation S under the Securities Act). No public offering of the Notes is being made in the United States.
Your right to access the Prospectus, the Final Terms and this service is conditional upon complying with the above requirement.
This information is provided by RNS